Case Study: a leading U.S.-headquartered biotechnology company achieves lower MPLS costs and greater network reliability with HCLTech Cisco SD-WAN

a leading u.S.-headquartered biotechnology company reduces MPLS costs with HCL SD-WAN

HCLTech assisted a leading U.S.-headquartered biotechnology company facing high costs and complexity from its mixed global network infrastructure, which included MPLS and other legacy connections. The client needed a transport-agnostic solution to reduce expenses, improve reliability, and gain centralized management for its operations in R&D, clinical trials, and manufacturing.

To address this, HCLTech implemented a comprehensive Cisco SD-WAN solution, including cloud controllers and infrastructure upgrades. This deployment by HCL achieved a significant reduction in yearly MPLS circuit costs, provided redundancy at each branch, and improved customer experience through aggregated throughput and automated failover.